Fig. 3.
ROS signaling in normal versus cancer cells. In normal cells, low levels of ROS can regulate controlled proliferation while high levels of ROS lead to cell death or senescence. Cancer cells with mutations in tumor suppressors can evade ROS induction of cell death or senescence. Thus, cancer cells exhibit high levels of ROS leading to uncontrolled cellular proliferation